These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11052803)
1. Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. Kalsi A; Kavarana MJ; Lu T; Whalen DL; Hamilton DS; Creighton DJ J Med Chem; 2000 Oct; 43(21):3981-6. PubMed ID: 11052803 [TBL] [Abstract][Full Text] [Related]
2. Bivalent transition-state analogue inhibitors of human glyoxalase I. Zheng ZB; Creighton DJ Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691 [TBL] [Abstract][Full Text] [Related]
3. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II. Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422 [TBL] [Abstract][Full Text] [Related]
4. A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides. Hamilton DS; Kavarana MJ; Sharkey EM; Eiseman JL; Creighton DJ J Med Chem; 1999 May; 42(10):1823-7. PubMed ID: 10346934 [TBL] [Abstract][Full Text] [Related]
5. Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. Cameron AD; Ridderström M; Olin B; Kavarana MJ; Creighton DJ; Mannervik B Biochemistry; 1999 Oct; 38(41):13480-90. PubMed ID: 10521255 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I Inhibitors. Jin T; Zhai J; Liu X; Yue Y; Huang M; Li Z; Ni C; Deng Q; Sang Y; Yao Z; Zhang H; Hu X; Zheng ZB Chem Pharm Bull (Tokyo); 2017 May; 65(5):455-460. PubMed ID: 28320998 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism. Al-Timari A; Douglas KT Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646 [TBL] [Abstract][Full Text] [Related]
8. QSAR of the inhibition of glyoxalase by S-substituted glutathiones. Silipo C; Hansch C Farmaco Sci; 1979 Jan; 34(1):3-10. PubMed ID: 553818 [TBL] [Abstract][Full Text] [Related]
9. Role of the N-terminus of glutathione in the action of yeast glyoxalase I. Douglas KT; Al-Timari A; D'Silva C; Gohel DI Biochem J; 1982 Nov; 207(2):323-29. PubMed ID: 7159385 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study. Thornalley PJ; Ladan MJ; Ridgway SJ; Kang Y J Med Chem; 1996 Aug; 39(17):3409-11. PubMed ID: 8765525 [TBL] [Abstract][Full Text] [Related]
11. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities. Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727 [TBL] [Abstract][Full Text] [Related]
12. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704 [TBL] [Abstract][Full Text] [Related]
13. Inhibition by active site directed covalent modification of human glyoxalase I. Holewinski RJ; Creighton DJ Bioorg Med Chem; 2014 Jul; 22(13):3301-8. PubMed ID: 24856185 [TBL] [Abstract][Full Text] [Related]
14. Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I. Sang Y; Shi Q; Mo M; Ni C; Li Z; Liu B; Deng Q; Creighton DJ; Zheng ZB Bioorg Med Chem Lett; 2015 Nov; 25(21):4724-4727. PubMed ID: 26320622 [TBL] [Abstract][Full Text] [Related]
15. An XAS investigation of product and inhibitor complexes of Ni-containing GlxI from Escherichia coli: mechanistic implications. Davidson G; Clugston SL; Honek JF; Maroney MJ Biochemistry; 2001 Apr; 40(15):4569-82. PubMed ID: 11294624 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors. More SS; Vince R J Med Chem; 2009 Aug; 52(15):4650-6. PubMed ID: 19610604 [TBL] [Abstract][Full Text] [Related]
17. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL J Med Chem; 1999 Jan; 42(2):221-8. PubMed ID: 9925727 [TBL] [Abstract][Full Text] [Related]
18. Catalytic mechanism of glyoxalase I: a theoretical study. Himo F; Siegbahn PE J Am Chem Soc; 2001 Oct; 123(42):10280-9. PubMed ID: 11603978 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by glutathione derivatives of bovine liver glyoxalase II (hydroxyacylglutathione hydrolase) as a probe of the N- and S-sites for substrate binding. Al-Timari A; Douglas KT Biochim Biophys Acta; 1986 Mar; 870(2):219-25. PubMed ID: 3955057 [TBL] [Abstract][Full Text] [Related]
20. Addition of hydrophobic side chains improve the apoptosis inducibility of the human glyoxalase I inhibitor, TLSC702. Azuma M; Inoue M; Nishida A; Akahane H; Kitajima M; Natani S; Chimori R; Yoshimori A; Mano Y; Uchiro H; Tanuma SI; Takasawa R Bioorg Med Chem Lett; 2021 May; 40():127918. PubMed ID: 33711442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]